Exchange: NYSE·Updated 09:52 AM EDT

BDX News

News
all
press releases
BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
BD expands U.S. pharmacy automation with Vmax 160 at Fairview to handle complex specialty and refrigerated medications.
Zacks
More News
BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview
BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at Fairview BD Advances Intelligent Robotics to Transform the Future of Pharmacy Care at FairviewPR NewswireFRANKLIN LAKES, N.J., Sept. 14, 2026First-of-its-kind U.S. deployment ofBD Vmax 160 expands pharmacy automation...
PR Newswire
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
Zacks
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation
BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation PR Newswire FRANKLIN LAKES, N.J., Aug. 27, 2026 STANCE trial surpasses a key enrollment milestone, advancing the...
PR Newswire
BD to Present at Wells Fargo 21st Annual Healthcare Conference
BD to Present at Wells Fargo 21st Annual Healthcare Conference BD to Present at Wells Fargo 21st Annual Healthcare Conference PR Newswire FRANKLIN LAKES, N.J., Aug. 26, 2026 FRANKLIN LAKES, N.J., Aug. 26, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
PR Newswire
Can Teleflex's OEM Sale and Higher EPS Outlook Reshape 2026 Returns?
TFX's $1.5B OEM sale cuts leverage and lifts 2026 EPS guidance, but weaker growth and margin pressure keep the outlook measured.
Zacks
BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study
BD concludes PREVENT trial enrollment, advancing Phasix Mesh toward a potential FDA submission for incisional hernia prevention.
Zacks
Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?
Integra's SurgiMend relaunch could support a broader 2027 recovery, but customer recapture and FDA approval remain key to the upside.
Zacks
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire PR Newswire FRANKLIN LAKES, N.J., Aug. 17, 2026 FRANKLIN LAKES, N.J., Aug. 17, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX...
PR Newswire
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally?
West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and productivity gains fuel the rally.
Zacks

Advertisement|Remove ads.